Carlos Bustamante, Galatea Bio
March 27, 2025 07:00 AM EDT
Financing
Startups

Galatea Bio gets $25M to map ge­net­ic di­ver­si­ty of 10 mil­lion peo­ple, help phar­ma cre­ate new med­i­cines

Kyle LaHucik

Senior Reporter

A Mi­a­mi start­up look­ing to se­quence the ge­net­ic di­ver­si­ty of 10 mil­lion peo­ple this decade has pulled in $25 mil­lion in to­tal fund­ing.

Galatea Bio …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

Fed­er­al judge nix­es FDA's lab-de­vel­oped test rule, says it ex­ceed­ed agen­cy's au­thor­i­ty

What’s next af­ter Marks? At FDA, ques­tions over more top ex­its and fu­ture vi­sion for drug agency

Marks’ ex­it at FDA rat­tles an al­ready tee­ter­ing biotech in­dus­try

Lil­ly's heart dis­ease drug could be dosed as lit­tle as once a year, study shows

Mer­ck’s PAH drug cuts risk of se­ri­ous events by 76% in tri­al stopped for ef­fi­ca­cy

sponsored

End­points we­bi­nar: In­side the “One Lon­za” strat­e­gy: Re-en­gi­neer­ing the fu­ture of CD­MO

A service from the Financial Times